Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1990 May-Jun;8(3):277-86.
doi: 10.1007/BF00141258.

Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties

Affiliations
Comparative Study

Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties

D Dus et al. Clin Exp Metastasis. 1990 May-Jun.

Abstract

The availability of lectin-resistant cell lines with altered carbohydrate moieties in cell surface glycoproteins and glycolipids has greatly facilitated study of the involvement of cellular glycoconjugates in tumor growth and metastasis. We present here a new animal model for metastasis study based on mouse Lewis lung carcinoma LL2 in vitro cell line. From this line, five lectin-resistant variant sublines were selected with the following lectins: wheat germ agglutinin (WGAR), Ricinus communis agglutinin II (RCA IIR) and Aleuria aurantia agglutinin (AAAR). The correlation of the lectin resistance with their in vitro and in vivo growth properties, and especially lung colonizing ability, were investigated. Three WGAR variants with well-preserved tumorigenicity revealed reduced metastatic ability, both spontaneous, after subcutaneous (s.c.) administration and experimental, after intravenous (i.v.) administration. The RCA IIR variant also possessed reduced spontaneous and experimental metastatic ability, but exhibited higher growth rate of local s.c. tumors. The AAAR variant possessed reduced spontaneous metastatic ability but its ability to colonize the lungs after i.v. administration was five-fold higher than that of the parent LL2 line, whereas its tumorigenicity remained unchanged. The relative differences among WGAR variants and parent LL2 line, concerning their experimental metastatic ability, remained similar in cyclophosphamide-modified mice to those in normal recipients.

PubMed Disclaimer

References

    1. J Biol Chem. 1985 Apr 25;260(8):4688-93 - PubMed
    1. Int J Cancer. 1986 May 15;37(5):723-30 - PubMed
    1. Biochim Biophys Acta. 1981 Aug 31;651(1):37-50 - PubMed
    1. Br J Cancer. 1983 Jan;47(1):81-9 - PubMed
    1. Cancer Metastasis Rev. 1985;4(3):221-60 - PubMed

Publication types

LinkOut - more resources